FDA
-
-
-
-
-
-
-
Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress
-
-
-
-
-
-
-
Jefferies Reiterates Hold Rating on Aurinia Pharmaceuticals (AUPH)
-
-
-
-
-
-
-
Aurinia Pharmaceuticals to Host Conference Call to Discuss AUR200 Phase 1 Study Results on June 30, 2025
-
-
-
-
-
-
-
Aurinia Pharmaceuticals to Release 2024 Fourth Quarter and Full Year Financial and Operational Results on February 27, 2025
-
-
-
-
-
-
-
Aurinia Pharmaceuticals to Release Third Quarter Financial and Operational Results on November 7, 2024
-
-
-
-
-
-
-
Aurinia Announces Board Restructuring
-
-
-
-
-
-
-
Aurinia Pharmaceuticals to Release Second Quarter Financial and Operational Results on August 1, 2024
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

